Literature DB >> 17650080

Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery.

S Rajagopalan1, I Ford, P Bachoo, G S Hillis, B Croal, M Greaves, J Brittenden.   

Abstract

OBJECTIVES: Myocardial ischemia is the leading cause of postoperative mortality and morbidity in patients undergoing major vascular surgery. Platelets have been implicated in the pathogenesis of acute thrombotic events. We hypothesized that platelet activity is increased following major vascular surgery and that this may predispose patients to myocardial ischemia.
METHODS: Platelet function in 136 patients undergoing elective surgery for subcritical limb ischemia or infrarenal abdominal aortic aneurysm repair was assessed by P-selectin expression and fibrinogen binding with and without adenosine diphosphate (ADP) stimulation, and aggregation mediated by thrombin receptor-activating peptide and arachidonic acid (AA). Cardiac troponin-I (cTnI) was performed.
RESULTS: P-selectin expression increased from days 1 to 3 after surgery [median increase from baseline on day 3: 53% (range: -28% to 212%, P < 0.01) for unstimulated and 12% (range: -9% to 45%, P < 0.01) for stimulated]. Fibrinogen binding increased in the immediate postoperative period [median increase from baseline: 34% (range: -46% to 155%, P < 0.05)] and decreased on postoperative day 3 (P < 0.05). ADP-stimulated fibrinogen binding increased on day1 (P < 0.05) and thereafter decreased. Platelet aggregation increased on days 1-5 (P < 0.05). Twenty-eight (21%) patients had a postoperative elevation (> 0.1 ng mL(-1)) of cTnI. They had significantly increased AA-stimulated platelet aggregation in the immediate postoperative period and on day 2 (P < 0.05), and non-response to aspirin (48% vs. 26%, P = 0.036).
CONCLUSIONS: This study has shown increased platelet activity and the existence of non-response to aspirin following major vascular surgery. Patients with elevated postoperative cTnI had significantly increased AA-mediated platelet aggregation and a higher incidence of non-response to aspirin compared with patients who did not.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17650080     DOI: 10.1111/j.1538-7836.2007.02694.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  8 in total

1.  Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Rebecca Dann; Tarik Hadi; Emilie Montenont; Ludovic Boytard; Dornaszadat Alebrahim; Jordyn Feinstein; Nicole Allen; Russell Simon; Krista Barone; Kunihiro Uryu; Yu Guo; Caron Rockman; Bhama Ramkhelawon; Jeffrey S Berger
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

Review 2.  The Perioperative Management of Antiplatelet and Anticoagulant Drugs in Hip Fractures: Do the Surgery as Early as Possible.

Authors:  Mohammad Ali Ghasemi; Ehsan Ghadimi; Ahmad Shamabadi; Sm Javad Mortazavi
Journal:  Arch Bone Jt Surg       Date:  2022-06

Review 3.  Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives.

Authors:  Weiliang Sun; Jingang Zheng; Yanxiang Gao
Journal:  Biomolecules       Date:  2022-01-25

4.  [Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].

Authors:  T Hummel; S H Meves; K Rüdiger; A Mügge; A Mumme; B Burkert; D Mühlberger; H Neubauer
Journal:  Chirurg       Date:  2016-05       Impact factor: 0.955

Review 5.  Patients who require non-cardiac surgery in acute coronary syndrome.

Authors:  Jeffrey D Wessler; Ajay J Kirtane
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

6.  Platelet activation increases in patients undergoing vascular surgery.

Authors:  Gabriel S Schneider; Caron B Rockman; Jeffrey S Berger
Journal:  Thromb Res       Date:  2014-08-23       Impact factor: 3.944

7.  Perioperative changes of response to antiplatelet medication in vascular surgery patients.

Authors:  Thomas Hummel; Saskia Hannah Meves; Andreas Breuer-Kaiser; Jan-Ole Düsterwald; Dominic Mühlberger; Achim Mumme; Horst Neubauer
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

8.  Efficacy and safety of a bridging strategy that uses intravenous platelet glycoprotein receptor inhibitors for patients undergoing surgery after coronary stent implantation: a meta-analysis.

Authors:  Fan Wu; Kanghua Ma; Rui Xiang; Baoru Han; Jing Chang; Zhong Zuo; Yue Luo; Min Mao
Journal:  BMC Cardiovasc Disord       Date:  2022-03-24       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.